Catalent Pharma Solutions, Inc. (CTLT)
Dec 18, 2024 - CTLT was delisted (reason: acquired by Novo Holdings)
63.48
0.00 (0.00%)
Inactive · Last trade price on Dec 17, 2024
Catalent Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Catalent stock had an average target of 63.4, with a low estimate of 63 and a high estimate of 63.5.
Price Target: $63.4 (-0.13%)
Analyst Consensus: Hold
* Price targets were last updated on Sep 24, 2024.
Analyst Ratings
The average analyst rating for Catalent stock from 6 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 0 | 0 | 0 | 0 |
| Hold | 6 | 6 | 7 | 7 | 7 | 6 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy → Hold Downgrades $64 | Buy → Hold | Downgrades | $64 | +0.03% | Sep 24, 2024 |
| William Blair | William Blair | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 3, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $64 | Hold | Reiterates | $64 | +0.03% | Jul 11, 2024 |
| Barclays | Barclays | Hold Maintains $47 → $63 | Hold | Maintains | $47 → $63 | -0.76% | Jun 28, 2024 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $64 | Hold | Reiterates | $64 | +0.03% | Apr 4, 2024 |
Financial Forecast
Revenue This Year
4.77B
from 4.38B
Increased by 8.77%
Revenue Next Year
5.17B
from 4.77B
Increased by 8.42%
EPS This Year
1.08
from -5.76
EPS Next Year
1.45
from 1.08
Increased by 34.50%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.1B | 5.6B | |||
| Avg | 4.8B | 5.2B | |||
| Low | 4.5B | 4.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 17.0% | 17.1% | |||
| Avg | 8.8% | 8.4% | |||
| Low | 2.6% | 1.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.34 | 2.21 | |
| Avg | 1.08 | 1.45 | |
| Low | 0.82 | -0.14 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 103.9% | |
| Avg | - | 34.5% | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.